SECOND SIGHT MED PRODS INC's ticker is EYESXXXX and the CUSIP is 81362J100. A total of 60 filers reported holding SECOND SIGHT MED PRODS INC in Q1 2016. The put-call ratio across all filers is 1.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $76,000 | – | 12,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,492,975 | $3,597,974,000 | 1.05% |
| &PARTNERS | 51,961 | $42,000 | 0.06% |
| Glassman Wealth Services | 72,366 | $58,000 | 0.02% |
| Sigma Planning Corp | 385,737 | $309,000 | 0.02% |
| HBK Sorce Advisory LLC | 100,000 | $80,000 | 0.01% |
| Fore Capital, LLC | 56,300 | $45,000 | 0.01% |
| WealthTrust Axiom LLC | 17,320 | $13,000 | 0.01% |
| B. Riley Wealth Management, Inc. | 40,800 | $33,000 | 0.01% |
| Semmax Financial Advisors Inc. | 7,290 | $6,000 | 0.00% |
| Ausdal Financial Partners, Inc. | 10,025 | $9,000 | 0.00% |